Case Study

We really learned a lot from JJELLYFISH's approach towards the U.S. market - right from day one. The way they researched the ICP, created personalized email campaigns, conducted meetings... it was all structured very well.

We were surprised how much we could learn from every customer call when they were targeted for exactly what we wanted to test for.

Having found success in Southeast Asia, the CrelioHealth team began focusing on how to best enter the US market. For this, CrelioHealth partnered with JJELLYFISH to better understand i) what differences might exist between the buyer profile in Asia vs. the U.S. and (ii) what unmet needs are most important for customers to solve today. These findings were critical to informing CrelioHealth's GTM approach and positioning for the U.S. market.

Unlike many other industries, the Independent Lab space poses several unique challenges. Mainly, it is difficult to generate a list of high-fit, discoverable prospects, which has downstream implications when considering a repeatable outbound sales motion.

Faced with these early and persistent ICP challenges, JJELLYFISH was still able to set up and execute a successful outbound strategy. In fact, the JJELLYFISH team developed a prospecting method that took

CrelioHealth's Reply Rates from under 1% to >10.5% - proving 10× growth in just under 8 weeks! Alongside the CrelioHealth Founder, JELLYFISH achieved 130% of the discovery meetings target with senior lab operations leaders in the U.S.

These discussions allowed CrelioHealth to better understand the maturity of the U.S. market, the sophistication of technology leveraged by independent labs, and existing pain points that demand a solution. Of all the prospects engaged, 38% were with C-Suite executives and 54% advanced to a secondary product demonstration (which unlocked further product-focused learnings).

Following the engagement, CrelioHealth adopted JJELLYFISH's model to test and validate alternative product lines in the U.S.

• 130% To Goal Discovery Meetings

• 7% Interest Rate Via Cold Outbound

• 54% Conversion From 1st Meeting